Summary.-We have previously documented the development and subsequent disappearance of cytolytic activity mediated by lymphocytes from lymph nodes draining Moloney sarcomas destined either to regress or grow progressively. We now report that these tumour-draining lymphnode cells (LNC) that were no longer cytotoxic, spontaneously regenerated peak levels of killing after culture in vitro for 4 days in the absence of exogenous tumour antigen. Cytolytic activity, which was antigenically specific, was mediated by T lymphocytes. Resurgence of cytolytic activity in vitro was accompanied by proliferative changes (DNA synthesis, blast transformation, cell division) which peaked on the 3rd day of culture. Although normal, nonimmune LNC underwent quantitatively similar proliferative changes in culture, the killing that developed was weak and antigenically nonspecific. Transfer of cultured, tumourdraining LNC to immunologically compromised, syngeneic mice conferred complete protection from Moloney sarcoma progression. Adoptive transfer could be delayed for 6 days after tumour induction without loss of protection. These results suggest that there exists in Moloney sarcoma-bearing mice a mechanism that limits the differentiation of pre-killer cells into cytolytically active T lymphocytes, and that such inhibition is eliminated when LNC are explanted into culture.
THE PRESENCE of cytolytic T lymphocytes in regressing Moloney sarcomas has been documented in a number of different laboratories (Plata et al., 1976; Holden et al., 1976; Gillespie et al., 1977) . We have additionally shown that T cells with lytic activity can be isolated directly from progressing Moloney sarcomas, but only during the early stages of tumour development (Gillespie et al., 1977) . Thereafter, T lymphocytes recovered either from progressing sarcomas or from the lymph nodes draining these lesions lacked the ability to kill (Gillespie and Russell, 1978) .
When non-cytolytic lymphnode cells (LNC) draining large progressing Moloney sarcomas were explanted into culture, they developed the capacity to kill again, in the absence of exogenous antigen. This resurgence of cytolytic activity was inhibited, however, by the presence of either soluble tumour antigen, macrophages (MO) or a combination of antigen and MO.
"Spontaneous" reactivation of cytolytic activity has been reported for lymphocytes from tumour-bearing or tumour-immune animals following overnight incubation (Sudo and Hashimoto, 1971; DeLandazuri and Herberman, 1972; Vasudevan et al., 1973, Laux and Lausch, 1974; Henney, 1976, 1977) or after repeated washing (Currie and Basham, 1972) . This rapid augmentation of cytolytic activity could be the result of a number of factors:
removal of the inhibitory influence of excess soluble antigen (Alexander et al., 1969; Baldwin et al., 1973) or loss of suppression mediated either by T lymphocytes (Kuperman et al., 1975; Fujimoto et al., 1976; Takei et al., 1977) or by macrophages (Parkhouse and Dutton, 1966; Kirchner et al., 1974; Wing and Remington, 1977) .
Because the continued presence of cytolytic T lymphocytes in vivo may contribute to host resistance to tumour cellgrowth, we wanted to understand better the phenomenon by which lytic activity was regained in vitro, once it had been lost in in vivo. We also wanted to determine the degree of protection against tumour progression conferred by cultured cells when they were transferred adoptively to immunologically compromised recipients. The results of our studies, which included lymphocytes derived from mice bearing regressing as well as progressing Moloney sarcomas, are reported here.
MATERIALS AND METHODS
Tumours and tumour-cell lines.-Regressing or progressing Moloney sarcomas were induced predictably in adult (6 or 8-week-old) BALB/c AnCr male mice by the i.m. (gastrocnemius) injection of 5 x 103 or 106 MSC cells, respectively (Russell et al., 1976b) . The MSC cell line, used to induce Moloney sarcomas, also served as the source of antigen-relevant target cells in lymphocyte-mediated cytolysis assays. Antigenically unrelated P815 mastocytoma cells were employed routinely to detect non-specific killing. The specificity of the lymphocyte-mediated cytolysis was investigated further in assays using 3 antigenirrelevant BALB/c cell lines established from 3-methylcholanthrene-induced fibrosarcomas.
Cell lines were maintained and cells harvested from culture as previously described (Gillespie et al., 1977 (Russell et al., 1976a; Gillespie and Russell, 1978) . Fe-receptor-bearing cells (mostly B lymphocytes and some macrophages) were depleted by incubation of LNC suspensions on monolayers of antibodysensitized sheep erythrocytes (Kedar et al., 1974 to each tube to slow cell metabolism, and the contents of each tube were deposited onto cellulose-acetate membranes (045 ,um pore size) by vacuum filtration. The cells retained on the filter membranes were washed with iced PBS, and lysed with 10 ml of iced trichloroacetic acid (10%). After dehydration of the retained material by washing with absolute ethanol, the acid-precipitated radioactivity was counted with an automatic gamma scintillation spectrometer. Mitotic activity was determined from the percentage of mitotic figures in Giemsastained cytocentrifuged preparations of LNC cultured for 3 h in the presence of vinblastine (10-7 g/ml). Blastogenesis was assessed on the basis of the percentage of cells with the characteristic morphological appearance of lymphoblasts, as determined by microscopic inspection of Giemsa-stained cytocentrifuge preparations made directly from cultured LNC.
LNC-mediated cytolysis assay.-Cytotoxicity of lymphocyte populations was determined using a 51Cr-release assay, and the cytotoxic activity of each preparation was expressed as the number of lytic units (LU) per 106 T lymphocytes. This assay and the calculation of LU have been described previously (Gillespie et al., 1977; Gillespie and Russell, 1978) and allow direct comparison of the relative cytolytic activities of different LNC populations.
Depletion of T lymphocytes in vivo.-Adult BALB/c mice were thymectomized, rested for 2 weeks, then irradiated (y-irradiation, 60Co source, 109 rad/min, 7 min) and reconstituted with 15 x 106 syngeneic marrow cells that had been treated with anti-theta and complement. These adult-thymectomized, irradiated, marrow-reconstituted mice (ATxBM) were used in experiments 30-60 days later. Animals that had thymic remnants revealed by necropsy at the end of each experiment were excluded.
RESULTS
Lymphnode cells draining regressing sarcomas behave in vitro similarly to those draining progressing sarcomas There were two objectives here: (1) to determine whether lymphnode cells draining Moloney sarcomas late in the course of regression would recover cytolytic activity in vitro, and (2) if so, to compare their response to that of LNC draining progressing Moloney sarcomas. As shown in Fig. 1 , regressor LNC responded similarly to progressor LNC. Peak levels of cytolytic activity, reached in both types of LNC cultures by the 4th day, were invariably higher for regressor populations, provided that the LNC cultures were initiated at the same time after tumour induction. After 4 days, cytolytic activity declined to preculture levels, usually within 8-11 days after cultures were started (data not shown).
The (., X.) was antigenically specific. The MSC cell. which had been used to induce the tumours, was killed efficiently. By comparison, cultured LNC were minimally cytolytic to cells from 3 antigenically dissimilar BALB/c sarcoma cell lines.
Resurgence of cytolytic activity in vitro was T-lymnphocyte-dependent and associated with proliferation
The killer cells generated in culture were T lymphocytes; cytolytic activity was abolished by treatment of cultured LNC with anti-theta serum and complement. Similar treatment with complement alone had no effect. Cytolytic activity that developed was susceptible to anti-theta treatment irrespective of whether cultures were initiated with cells taken from lymph nodes draining regressing or progressing sarcomas.
Proliferative activity, documented by: (1) uptake of 125I-IUdR into newly synthesized DNA, (2) counting of mitotic figures in cultures exposed for 3 h to vinblastine, and (3) quantification of blast cells in Giemsa-stained cytocentrifuge preparation, reached peak levels after 3 days of culture ( Fig. 2(a) ), one day before the peak of cytolytic activity. Cell proliferation was insufficient, however, to keep pace with cell losses that occurred in vitro. This fact was reflected by the steadily declining recovery values that were obtained as time in culture increased ( Fig. 2(b) ). While they were never as cytolytic, cultured LNC from mice with progressing sarcomas were closely similar quantitatively to cultured regressor LNC with regard to percentages of T and B lymphocytes, recovery, and proliferative activity.
While development of cytolytic activity by cultured LNC from tumour-bearing mice may have required proliferation of precursor killer cells, cell division per se was not sufficient to induce cytolytic activity in cultures of LNC from normal mice. Indices of proliferation on Day 5 had reached levels comparable to those obtained in 3 days using LNC from tumourbearing mice (Fig. 3(a) ). In spite of comparable levels of proliferation, the cytolytic activity measured was low (3.4 LU/ 106 T cells vs MSC targets) and relatively non-specific (2.2 LU/106 T cells vs P815 mastocytoma cells (Fig. 3(a) ). By contrast, the cytolytic activity mediated in this same experiment by cultured regressor LNC was 40, 181 and 82 LU/106 T cell vs MSC cells, at 3, 4 and 5 days respectively, without detectable killing of P815 targets. Cell recoveries during the first days of culture of normal LNC were poorer than when LNC from tumoured mice were used (Fig. 3(b) ). Because of this fact, normal LNC cultures were not monitored after 5 days.
Effect of culture conditions on cytolytic activity
The 2-ME included in cultures was not directly responsible for inducing the high levels of killing which was directed at MSC cells. This fact is shown in the Table, where results are given from an experiment in which normal and regressor LNC were cultured either with or without 2-ME. In the absence of 2-ME, cell losses for both populations were increased, and proliferative and cytolytic activities were substantially reduced. The presence of 2-ME (5 x 10-5M) accentuated the killing capacity for tumour-draining LNC without inducing significant levels of non--specific cytoxicity. Under identical culture conditions, 2-ME caused non-immune LNC to develop a low but significant cytolytic capability that was completely non-specific.
Because macrophages had previously been shown to inhibit the development of cytotoxicity in vitro (Gillespie and Russell, 1978) , we examined the effect of removing the few M0 that were normally present in our LNC populations, along with other Fe-receptor-bearing types either before or after culture. LNC suspensions depleted of MO before culture mediated levels of tumour-specific killing (43 and 55 LU/106 T cells after 2 and 4 days, respectively) that were comparable to those of LNC (Russell and Cochrane, 1974) . Tumour size increased roughly linearly in mice that received either physiological saline or cultured, nonimmune LNC. Mice injected with cultured, tumour-draining LNC rejected their tumours completely, even with a period as long as 6 days between tumour induction and adoptive transfer (Fig. 4) . The minimum number of cultured, tumour-draining LNC required to prevent Moloney sarcoma progression in immunologically compromised hosts was determined by administering 2, 4 or 8 x 106 cultured immune lymphocytes 1 day after inoculation of 5 x 103 MSC cells. As illustrated in Fig. 5 
DISCUSSION
Results of the experiments described here and in earlier publications (Gillespie et al., 1977; Gillespie and Russell, 1978) allow 3 conclusions to be drawn about tumour-T-lymphocyte interrelationships in the Moloney system: (1) an in vivo control mechanism stops the production of cytolytic T lymphocytes in lymphnodes draining either regressing or progressing Moloney sarcomas; (2) after they have reached a non-cytolytic state, explantation of T lymphocytes from tumourdraining lymph nodes into culture releases them from whatever influence it is that prevents the production of killer cells in vivo, allowing a resurgence of cytolytic activity in vitro: and (3) cytolytic cells generated from non-cytolytic T lymphocytes in tumour-draining lymph nodes have powerful protective effects against tumour progression in vivo.
We have documented previously the functional activity in vitro of T lymphocytes isolated directly from regressing or progressing Moloney sarcomas, or from the lymph nodes draining these tumours (Gillespie et al., 1977 ; Gillespie and Russell, 1978) . Early in tumour development, specific cytotoxic activity was demonstrable. T lymphocytes recovered later were progressively less cytolytic, with virtual loss of this ability coinciding with either the onset of tumour progression or the disappearance of regressing sarcomas. In the experiments reported here, we confirmed an earlier observation that noncytolytic T cells from the lymph nodes draining progressing Moloney sarcomas spontaneously regenerated their cytolytic activity when cultured in vitro. We have additionally shown that a similar response follows the explantation of non-cytolytic cells from lymph nodes that are draining sarcomas in the advanced stages of regression. In either case killing, which was highly specific, was shown to be lymphocyte-dependent and increased to peak levels after 4 days of culture. Increased cytolytic activity of cultured LNC was associated with marked proliferation (DNA synthesis, blast transformation, cell division), which was maximal by the 3rd culture day. Both proliferative and cyto-371 3 toxic activities declined sharply after their respective peak levels were attained. Quantitatively, T lymphocyte populations from lymph nodes draining regressing Moloney sarcomas consistently reached higher peak levels of cytotoxic activity tn vitro than populations from mice bearing progressing sarcomas. Proliferation per se was not responsible for the production of killer T cells, however, as unsensitized LNC cultured under the same conditions failed to develop comparable levels of cytolysis, even though they did undergo substantial proliferation in vitro.
These changes do not appear to be unique to the Moloney system. Several groups of investigators (Sudo and Hashimoto, 1971; DeLandazuri and Herberman, 1972; Vasudevan et al., 1973; Laux and Lausch, 1974; Henney, 1976, 1977) have observed that cytolytic activity, mediated by T lymphocytes from tumour-bearing or tumour-immune animals, was augmented significantly if they were held in culture before challenging them with target cells in vitro. It is not possible to determine whether the resurgence of killing in the first 4 reports was other than qualitatively similar to what we observed, since full examinations of the characteristics of the cells were not made. Henney (1976, 1977) , however, have described in detail a somewhat analogous phenomenon in an allogeneic situation. These workers concluded that 24 h of incubation in vitro was sufficient for the differentiation of pre-killer T cells into cytolytic effector cells. This differentiation process, which was dependent upon protein synthesis but independent of DNA synthesis or antigenic stimulation, was shown to be distinct from the antigen-driven pathway by which memory cells are specifically activated in vitro. This "spontaneous augmentation" of allogeneic T-cell-mediated killing was not affected by addition of alloantigen, and was greatest before and during the peak in vivo response. Thereafter, antigenic stimulation was required for a substantial in vitro response (presumably via memorycell activation). By contrast, we have observed that the dramatic in vitro resurgence of cytotoxicity that occurred 4-6 days after the peak cytolytic activity in tumour-bearing mice was suppressed by the addition of exogenous antigen to the culture (Gillespie and Russell, 1978) .
In an extension of their previous findings, Djeu et al. (1976) established that cooperation among T lymphocytes, complement-receptor lymphocytes and macrophages was required for spontaneous reactivation of killer cells after in vitro incubation (16-24 h) of non-cytolytic spleen cells from tumour-immune rats. However, these reactivated killer cells were not T lymphocytes, but were identified as complement-receptor lymphocytes.
Our results therefore may resemble more closely those obtained in a system using hapten-conjugated spleen cells instead of tumour cells as the inoculum (StarzinskiPowitz et al., 1976) . Specifically, cytolytic T lymphocytes were demonstrated inconsistently in lymph nodes draining inoculation sites; however, when these LNC were cultured for 48-72 h, potently cytolytic T cells developed by a proliferation-dependent pathway. Subsequent work by these investigators has demonstrated that in vitro differentiation of pre-killer T cells into cytolytic effector cells is blocked by a T lymphoblast that is cyclophosphamide-sensitive Rollinghoff et al., 1977) .
The mechanism responsible for regulating the development of killer T cells in vivo remains unclear. To hypothesize a single pathway is, perhaps, naive. For example, we have shown that soluble tumour antigen, macrophages, or a combination of these interfered with resurgence of cytolytic activity in vitro (Gillespie and Russell, 1978) . These observations are consonant with a large body of evidence that both excess tumour antigen (Alexander et al., 1969; Currie and Basham, 1972 ; reviewed in Kamo and Friedman, 1977) or macrophages (Parkhouse and Dutton, 1966; Kirchner et al., 1974; Wing and Remington, 1977) can suppress anti-tumour responses in vitro and in vivo. Clearly, these may not be the principal factors for, as demonstrated in the experiments reported here, lytic activity diminished spontaneously after the 4th day in culture, in spite of the fact that tumour cells (i.e. a source of new tumour antigen) and Fc-receptor-bearing cells (including MO) had been depleted. Loss of cytotoxic activity in association with reduced proliferative activity is a characteristic feature shared with the previously described in vitro anti-hapten response (StarzinskiPowitz et al., 1976) and the long-term mixed-leucocyte culture system that has been investigated so thoroughly by MacDonald and his colleagues (1974 a, b; reviewed by Engers and MacDonald, 1975) . In view of these considerations, and since the T lymphocyte was the predominant cell type remaining in our experiments, we are currently investigating the contribution that suppressor T cells generated in v)itro during the proliferative phase may have to the continued production of cytolytic T cells.
The results of adoptive-transfer experiments that we conducted suggest how important continued production of killer T cells might be to the survival of tumourbearing hosts. Cytolytic T lymphocytes, generated in vitro from non-cytolytic precursor cells from lymph nodes draining tumours, protected immunologically deficient mice bearing Moloney sarcomas. Sarcoma growth was slowed greatly by 4 x 106 of these cells administered i.v., and 8 x 106 afforded complete protection, even when tumours were allowed 6 days in which to become established. These results should not be interpreted to mean that T-lymphocyte-mediated killing of neoplastic cells within the tumours was the mechanism of protection. Several other possibilities must be considered. For example, in preliminary experiments (not described) draining lymphnode T lymphocytes activated in vitro as we have described had the capacity to activate macrophages to become non-specifically cytolytic for tumour cells. Such an indirect mechanism may ultimately be shown to be equally important to, or even more important than, the direct mediation of cytotoxicity.
Note added in proof: Schechter and Feldman (1978, Israel J. Med. Sci., 14, 131) have observed that spleen cells cultured in vitro from tumour (3LL)-bearing C57BL/6 mice regenerated cytolytic activity, and in Wynn-type transfer experiments significantly delayed tumour development.
